
Vitalhub Corp. (TSE:VHI - Free Report) - Cormark decreased their FY2025 EPS estimates for shares of Vitalhub in a report issued on Tuesday, July 8th. Cormark analyst G. Fairweather now expects that the company will post earnings of $0.11 per share for the year, down from their prior estimate of $0.12. The consensus estimate for Vitalhub's current full-year earnings is $0.23 per share. Cormark also issued estimates for Vitalhub's FY2027 earnings at $0.45 EPS.
Other equities research analysts have also issued research reports about the stock. National Bank Financial raised shares of Vitalhub to a "strong-buy" rating in a research note on Monday, June 9th. Scotiabank lifted their price target on shares of Vitalhub from C$14.00 to C$14.50 and gave the company an "outperform" rating in a research report on Friday, June 20th. Raymond James Financial lifted their price target on shares of Vitalhub from C$13.50 to C$14.00 and gave the company an "outperform" rating in a research report on Friday, June 20th. TD Securities lifted their price target on shares of Vitalhub from C$13.00 to C$14.00 and gave the company a "buy" rating in a research report on Monday, March 31st. Finally, National Bankshares set a C$14.00 price target on shares of Vitalhub and gave the company an "outperform" rating in a research report on Tuesday, June 10th. Six research analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Vitalhub presently has a consensus rating of "Buy" and an average target price of C$13.25.
Get Our Latest Analysis on Vitalhub
Vitalhub Stock Down 0.6%
Shares of VHI traded down C$0.08 during trading hours on Wednesday, reaching C$12.45. 204,008 shares of the company traded hands, compared to its average volume of 127,570. The company's fifty day moving average price is C$10.86 and its two-hundred day moving average price is C$10.61. The company has a market capitalization of C$673.45 million, a price-to-earnings ratio of 202.49, a price-to-earnings-growth ratio of 1.18 and a beta of 1.26. Vitalhub has a 12 month low of C$6.74 and a 12 month high of C$12.72.
Insider Transactions at Vitalhub
In other news, Director Francis Nelson Shen bought 25,000 shares of the firm's stock in a transaction on Friday, May 16th. The stock was acquired at an average cost of C$10.23 per share, with a total value of C$255,750.00. Company insiders own 18.57% of the company's stock.
About Vitalhub
(
Get Free Report)
Vitalhub Corp., together with its subsidiaries, provides technology solutions for health and human service providers in Canada, the United States, the United Kingdom, Australia, Western Asia, and internationally. Its solutions include electronic healthcare record, case management, care coordination and optimization, and patient flow, engagement, and operational visibility solutions.
See Also

Before you consider Vitalhub, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vitalhub wasn't on the list.
While Vitalhub currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.